Question 1

How many shares of MLTX does MORGAN STANLEY own?

Accepted Answer

As of 2026-Q2, MORGAN STANLEY holds 563,602 shares of MLTX (MOONLAKE IMMUNOTHERAPEUTICS).

Question 2

What is MORGAN STANLEY's MLTX position worth?

Accepted Answer

As of 2026-Q2, MORGAN STANLEY's MLTX position is worth $11M.

Question 3

Is MORGAN STANLEY buying or selling MLTX?

Accepted Answer

In 2026-Q2, MORGAN STANLEY decreased their MLTX position (-8.3% change in shares).

Question 4

When did MORGAN STANLEY first buy MLTX?

Accepted Answer

Based on available 13F filings, MORGAN STANLEY first reported a position in MLTX in 2024-Q2. They have held the position across 9 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	563,602	-8.3%	$11M	0.0%	$19.47	0
2026-Q1	Decreased	614,482	-41.2%	$11.5M	0.0%	$17.69	0
2025-Q4	Increased	1M	+307.0%	$13.8M	0.0%	$13.21	45
2025-Q3	Increased	256,655	+493.6%	$1.8M	0.0%	$6.24	42
2025-Q2	Decreased	43,239	-20.4%	$2M	0.0%	$47.52	0
2025-Q1	Increased	54,331	+15.2%	$2.1M	0.0%	$39.86	30
2024-Q4	Decreased	47,144	-63.9%	$2.6M	0.0%	$53.02	0
2024-Q3	Increased	130,598	+89.2%	$6.6M	0.0%	$49.40	43
2024-Q2	New	69,027	-	$3M	0.0%	$43.97	37

MLTX9 quarters

MLTX
9 quarters